Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Inhibition of sodium-calcium exchange in cardiac sarcolemmal membrane vesicles. 2. Mechanism of inhibition by bepridil

Journal Article · · Biochemistry; (United States)
DOI:https://doi.org/10.1021/bi00407a024· OSTI ID:5210612
Bepridil, an antiarrhythmic agent, inhibits Na-Ca exchange in cardiac sarcolemmal membrane vesicles by a novel mechanism, different from that determined for amiloride analogues. Bepridil causes partial inhibition of Na/sub o/-dependent /sup 45/Ca/sup 2 +/ efflux. Inhibition of Na-Ca exchange is noncompetitive vs Ca/sup 2 +/ but competitive vs Na/sup +/ in both K/sup +/ and sucrose. Bepridil also blocks Ca-Ca exchange, with or without K/sup +/ present. However, K/sup +/ has two effects on inhibition: it reduces the potency of bepridil and causes inhibition to become partial. Inhibition of Ca-Ca exchange displays noncompetitive kinetics vs Ca/sup 2 +/ in either sucrose of K/sup +/. Dixon analyses of Na-Ca exchange inhibition caused by mixtures of bepridil and amiloride analogues demonstrate that these compounds produce a competitive interaction at a common carrier site that is evident only a low concentrations of amiloride inhibitors. Hill plots of bepridil inhibition of Na-Ca and Ca-Ca exchange display unitary Hill coefficients. These results indicate that bepridil interacts at only one substrate-binding site, the site selective for Na/sup +/, where amiloride analogues also preferentially interact. However, unlike amiloride, bepridil does not interact at the common Na/sup +/, Ca/sup 2 +/-binding site of the carrier. During stimulation of Ca-Ca exchange, K/sup +/ may bind at other sites besides the site selective for Na/sup +/, because in addition to being competitive with bepridil, it prevents complete abolition of Ca-Ca exchange, suggesting that this Na/sup +/ site is not involved in carrier turnover. These findings indicate the bepridil is a mechanisms-based Na-Ca exchange inhibitor that interacts at a transporter site which binds Na/sup +/ but not Ca/sup 2 +/
Research Organization:
Merck Institute for Therapeutic Research, Rahway, NJ (USA)
OSTI ID:
5210612
Journal Information:
Biochemistry; (United States), Journal Name: Biochemistry; (United States) Vol. 27:7; ISSN BICHA
Country of Publication:
United States
Language:
English